/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Andrew Blauvelt

Trinity College Dublin(IE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

805

Papers

36.8K

Citations

92

h-index

303

i10-index

Andrew Blauvelt is an academic researcher from Trinity College Dublin. The author has contributed to research in topics: Psoriasis: Treatment and Pathogenesis & Dermatology and Skin Diseases & Asthma and respiratory diseases. The author has an h-index of 92, co-authored 685 publications.

ORCID: 0000-0002-2633-985X

Research Topics

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Asthma and respiratory diseases Pharmaceutical studies and practices Health Systems, Economic Evaluations, Quality of Life

Papers by this author

works

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

2017 · Journal of the American Academy of Dermatology · 838 citations

https://doi.org/10.1016/j.jaad.2016.11.041

Andrew Blauvelt Kim Papp C.E.M. Griffiths B. Randazzo

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis

2018 · Clinical Reviews in Allergy & Immunology · 703 citations

https://doi.org/10.1007/s12016-018-8702-3

Andrew Blauvelt Andrea Chiricozzi

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

2018 · The Lancet · 627 citations

https://doi.org/10.1016/s0140-6736(18)31713-6

Kenneth B. Gordon Bruce Strober Mark Lebwohl Matthias Augustin

Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

2019 · Journal of the American Academy of Dermatology · 248 citations

https://doi.org/10.1016/j.jaad.2019.07.074

Mette Deleuran Diamant Thaçi Lisa A. Beck Marjolein de Bruin‐Weller

Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes

2018 · Drugs · 208 citations

https://doi.org/10.1007/s40265-018-0881-y

Hillel P. Cohen Andrew Blauvelt Robert M. Rifkin Silvio Danese

Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro.

1995 · The Journal of Immunology · 177 citations

https://doi.org/10.4049/jimmunol.154.9.4851

Claes D. Enk Dvora Sredni Andrew Blauvelt Seymour Katz

Research topics

topics

Psoriasis: Treatment and Pathogenesis

Dermatology and Skin Diseases

Asthma and respiratory diseases

Pharmaceutical studies and practices

Health Systems, Economic Evaluations, Quality of Life

Chat about Author

Papers

Chat

Click to start Chat